5 December 2020
Efficacy and safety of bemcentinib in patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia failing Hypomethylating Agents
Selective AXL inhibitors
5 December 2020
Efficacy and safety of bemcentinib in patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia failing Hypomethylating Agents
Please remember to confirm your email by clicking on the link provided in the subscription confirmation email. We will save your name and email address with the sole purpose of sending information regarding our latest news and events. By subscribing to BerGenBio’s newsletter you consent to our Privacy Policy and Terms of Use.